Dupilumab Improves Asthma Control Among Children Despite Duration of Condition
In this analysis, investigators found consistent benefits over placebo among children with type 2 asthma treated with dupilumab, regardless of condition length.
Related Articles
Skin of Color Savvy: News Update—The Power of Mentorship & Collaboration in Medicine
This June 17, 2025 SOCS News Update highlights creating strategic plans with mentors and mentees.
Pitolisant Shows Benefit for IH in Phase 3 Open-Label Trial, with Bruce Corser, MD
At SLEEP 2025, Bruce Corser, MD, discussed promising open-label data on pitolisant’s impact on idiopathic hypersomnia symptoms with HCPLive.
Kidney Compass: Key Updates in IgA Nephropathy at ERA 2025, with Chee Kay Cheung, MBChB, PhD
A deep dive into several noteworthy IgAN studies presented during the ERA 2025 Congress.
Postpartum Sleep Improves in Length, Not Quality, with Teresa Lillis, PhD
By week 2 postpartum, sleep duration rebounds, but fragmented sleep persists through week 13, Teresa Lillis, PhD, presented at SLEEP 2025.
FDA Approves First Twice-Yearly HIV Prevention Option
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Hispanic Ethnicity Tied to Severe Sleep Disordered Breathing, with Harneet Walia, MD
At SLEEP 2025, Walia discussed findings showing Hispanic individuals may experience more severe cases of sleep disordered breathing compared to the non-Hispanic group.
Pitolisant Shows Benefit for IH in Phase 3 Open-Label Trial, with Bruce Corser, MD
At SLEEP 2025, Bruce Corser, MD, discussed promising open-label data on pitolisant’s impact on idiopathic hypersomnia symptoms with HCPLive.
Plaque Psoriasis | Medical News & Expert Insight | HCPLive
The plaque psoriasis condition center is a comprehensive resource for clinical news and expert insights on plaque psoriasis. Read more at HCPLive.
RLS Guidelines Advise Against Dopamine Agonists, With John Winkleman, MD, PhD
At SLEEP 2025, Winkelman discussed the AASM’s updated guidelines urging clinicians to transition patients with RLS off dopamine agonists due to augmentation risks.
Skin of Color Savvy: News Update—The Power of Mentorship & Collaboration in Medicine
This June 17, 2025 SOCS News Update highlights creating strategic plans with mentors and mentees.